Tag: gastric volvulus treatment market report

  • Key Insights into the Gastric Volvulus Treatment Market’s Growth Opportunities for 2024-2033

    Key Insights into the Gastric Volvulus Treatment Market’s Growth Opportunities for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Estimated Growth Rate for the Gastric Volvulus Treatment Market Between 2024 and 2033?

    The market for gastric volvulus treatment has shown significant growth in the past few years. The market will expand from a size of $25.6 billion in 2023 to a larger $27.18 billion in 2024, representing a compound annual growth rate (CAGR) of 6.2%. The surge in growth during the historic period can be credited to factors like the forward strides in surgical methodologies, enhanced diagnostic resources, an increase in awareness and education, a spike in minimally invasive operations, and the impact of research and clinical studies.

    The market size for gastric volvulus treatment is projected to experience robust growth in the upcoming years, reaching $34.63 billion in 2028 with a compound annual growth rate (CAGR) of 6.2%. The market’s expansion during the forecast period can be credited to regulatory shifts and approvals, advancements in surgical procedures, an expanding senior population, tailored treatment programs, and the use of cutting-edge imaging methods. Major progressions expected during this forecast period consist of less invasive surgical methods, heightened awareness and early intervention, research into treatment methods, cooperative medical practices, and personalized treatment strategies.

    Claim Your Free Sample of the Global Gastric Volvulus Treatment Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

    What Are the Primary Contributors to the Growth of the gastric volvulus treatment Market?

    The upward trend in the elderly population is anticipated to boost the expansion of the gastric volvulus treatment market. The term “geriatric population” pertains to individuals aged 65 and over. Due to weakened immune systems and the advanced age, myriad conditions, including gastric volvulus, plague this age group, particularly individuals above 50. Hence, an increase in the geriatric populace is likely to fuel the market growth. For instance, America’s Health Rankings, a collaboration between the United Health Foundation and the American Public Health Association, reported in November 2022 that over 55.8 million individuals aged 65 and older resided in the United States in 2021, accounting for almost 16.8% of the country’s overall populace. Consequently, the rising number of older persons is steering the growth of the gastric volvulus treatment market.

    Which Key Segments Comprise the Gastric Volvulus Treatment Market?

    1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

    2) By Treatment Type: Medication, Surgery

    3) By Route of Administration: Oral, Parenteral

    4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

    5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

    What Are the Key Trends Reshaping the Gastric Volvulus Treatment Market?

    A key trend that is becoming increasingly popular in the gastric volvulus treatment market is product innovation. Established companies in the market are producing new, innovative products to maintain their position in the market. In October 2023, Pfizer Inc., an American pharmaceutical company, revealed that their product VELSIPITY (etrasimod) was given approval by the U.S. Food and Drug Administration (FDA). This product, a once-daily oral sphingosine-1-phosphate (S1P) receptor activator, is intended for individuals suffering from moderate to severe active ulcerative colitis (UC). The recommended dosage for VELSIPITY is 2 mg. VELSIPITY provides a steroid-free solution for adults with moderately to severe UC in the form of an oral, daily pill that offers a beneficial risk-benefit profile. The FDA’s validation of VELSIPITY signifies a game-changing moment for UC patients in need of innovative treatments for this chronic disease and who are prepared to take advanced therapy.

    Order Now for Fast Delivery of Your Gastric Volvulus Treatment Market Report!

    https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

    What Are the Top Regions Fueling Growth in the Gastric Volvulus Treatment Market?

    North America was the largest region in the gastric volvulus market in 2023. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Gastric Volvulus Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the gastric volvulus treatment market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Gastric Volvulus Treatment Market Include

    1. Gastric Volvulus Treatment Market Executive Summary

    2. Gastric Volvulus Treatment Market Segments

    3. Gastric Volvulus Treatment Market Size And Template Market Growth Rate

    4. Key Gastric Volvulus Treatment Market Trends

    5. Major Gastric Volvulus Treatment Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Gastric Volvulus Treatment Market

    26. Top Gastric Volvulus Treatment Companies

    27. Gastric Volvulus Treatment Market Opportunities And Strategies

    28. Gastric Volvulus Treatment Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Gastric Volvulus Treatment Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Gastric Volvulus Treatment Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The gastric volvulus treatment market is witnessing significant growth driven by the rising geriatric population.

    • Older adults over 65 years are prone to various diseases, including gastric volvulus.
    • In 2021, the United States had over 55.8 million people aged 65 and above, constituting nearly 16.8% of the total population.
    • Major players include PAI Pharma, Sun Pharmaceutical Industries Ltd., Pfizer Inc., and GlaxoSmithKline PLC.

    Product Innovation In Gastric Volvulus Treatment Market
    Product innovation is a key trend driving the gastric volvulus treatment market.

    • Pfizer Inc. introduced VELSIPITY (etrasimod), an oral sphingosine-1-phosphate (S1P) receptor activator for moderate to severe active ulcerative colitis.
    • Pfizer’s acquisition of Arena Pharmaceuticals for $6.7 billion bolsters expertise in inflammation and immunology, expanding therapeutic options.
    • Companies strive to develop novel therapies and improve patient outcomes.

    Market Segmentation and Treatment Trends
    The gastric volvulus treatment market offers various treatment options and routes of administration.

    1. By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus.
    2. By Treatment Type: Medication, Surgery.
    3. By Route of Administration: Oral, Parenteral.
    4. By Distribution Channel: Hospital Pharmacy, Retail Pharmacy.
    5. By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users.

    Regional Insights: North America Leads, Asia-Pacific Emerges
    North America dominates the gastric volvulus treatment market, with Asia-Pacific emerging as the fastest-growing region.

    • North America’s robust healthcare infrastructure and high prevalence of gastric volvulus contribute to market dominance.
    • Asia-Pacific’s growth is fueled by rising healthcare expenditure and increasing awareness of gastrointestinal disorders.

    Future Outlook and Conclusion
    The gastric volvulus treatment market is poised for substantial growth.

    • Regulatory changes, innovations in surgical procedures, and a growing geriatric population are key drivers.
    • Minimally invasive surgical techniques and personalized treatment plans enhance patient care.
    • Collaboration among medical practitioners and customized treatment approaches optimize outcomes.
    • With North America leading and Asia-Pacific rapidly growing, the market is projected to reach $34.63 billion by 2028.
    • As the global population ages and healthcare technologies evolve, the demand for effective gastric volvulus treatments remains strong, ensuring continued market expansion.

    View More On The Gastric Volvulus Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

    Request A Sample Of The Global Gastric Volvulus Treatment Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9382&type=smp